PMS35 Cost-Effectiveness of Tocilizumab for the Treatment of Active Rheumatoid Arthritis (RA) Patients With Inadequate Response to Anti-TNF Treatment in Turkey
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1390
https://www.valueinhealthjournal.com/article/S1098-3015(12)03103-8/fulltext
Title :
PMS35 Cost-Effectiveness of Tocilizumab for the Treatment of Active Rheumatoid Arthritis (RA) Patients With Inadequate Response to Anti-TNF Treatment in Turkey
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03103-8&doi=10.1016/j.jval.2012.08.1390
First page :
A445
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
887